tirzepatide sglt2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Unveiling the Therapeutic Potential of

Mechanism of action Both Mounjaro and Wegovy work by targeting hormones involved in appetite, blood sugar control, and digestion

Are there any side effects or risks with Tirzepatide

97 , E1023E1031 (2012)

Not hazy

Benefits of Tirzepatide for Weight Loss Based on clinical trials, patients using Tirzepatide may experience: Substantial A1C reductions Increased weight loss Improvements in cardiometabolic measures Improved triglycerides levels Reduced appetite Decreased blood pressure Improved insulin sensitivity Conclusion Tirzepatide had an overall safety and tolerability profile, similar to other therapies approved for the treatment of obesity